Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February 2013 Volume 5 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February 2013 Volume 5 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

The value of T2*-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families

  • Authors:
    • Xue-Wu Liu
    • Shu-Hua Wang
    • Zhao-Fu Chi
    • Li-Jun Su
    • Xiu-He Zhao
    • Sheng-Jun Wang
  • View Affiliations / Copyright

    Affiliations: Department of Neurology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China
  • Pages: 448-452
    |
    Published online on: November 30, 2012
       https://doi.org/10.3892/etm.2012.845
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of this study was to investigate the value of T2*-weighted gradient echo imaging (GRE T2*-WI) for the detection of familial cerebral cavernous malformation (FCCM). Twenty-six members of 2 families with FCCM were examined using computed tomography (CT), conventional magnetic resonance imaging (MRI) and GRE T2*-WI sequences. We identified 12 cases of FCCM using GRE T2*-WI sequences. These 12 patients had multiple lesions (mean 23). The lesions were most commonly located in the ganglia. Other areas included the cortex-subcortex, thalamus, cerebellum and brainstem. These lesions appeared as a reticulated core of mixed signal intensity with a surrounding rim of decreased signal intensity representing hemosiderin from previous hemorrhages. The mean numbers of lesions and cases of FCCM identified by various conventional MRI sequences were 5-17 and 3-9, respectively. Conventional MRI examination involved T1‑weighted imaging (T1WI), T2-weighted imaging (T2WI), T2‑fluid‑attenuated inversion recovery (T2Flair), diffusion‑weighted imaging (DWI) and spin-echo imaging (SE) sequences, in that order. The numbers of lesions identified by MRI were fewer than those identified by GRE T2*-WI. CT only identified 3 cases with large lesions combined with hemorrhage and calcification. These findings suggest that GRE T2*-WI is the first choice when diagnosing FCCM compared with CT and conventional MRI.

Introduction

Computed tomography (CT) is an important method for the diagnosis of cerebral cavernous malformation (CCM) prior to the clinical application of magnetic resonance (MR). However, only large CCM lesions complicated with hemorrhage and calcification are visible in a CT scan. In addition, diagnoses of microangioma or CCM in the posterior cranial fossa and brainstem have been missed (1,2). Magnetic resonance imaging (MRI) has gradually improved the sensitivity of the diagnosis of CCM following the widespread use of MR, but certain sequences have conspicuous limitations. The definitive diagnosis rate of CCM almost equals that obtained from autopsy results when T2*-weighted gradient echo imaging (GRE T2*-WI) is used (3,4). GRE T2*-WI has been considered to be the most important diagnostic tool for CCM. Twelve patients, of which 2 were diagnosed with familial cerebral cavernous malformation (FCCM) from August, 2005 to June, 2007, were easily diagnosed with CCM by GRE T2*-WI following brain CT and conventional MRI examination.

Materials and methods

Patients

Twelve of 26 members in two families were diagnosed with FCCM (8 male, 4 female, aged 8 to 74 years, mean age 36.5). All patients were subjected to brain CT and conventional MR scans prior to GRE T2*-WI. Various symptoms were recorded, including repeated history of headache and dizziness (4 patients), hemiparalysis (4 patients), hemianesthesia (3 patients), speech disfluency (2 patients), hydroposia bucking and dysphagia (2 patients), seizure (1 patient), hemiablepsia (1 patient), skin angioma (6 patients) and asymptomatic manifestations (6 patients). Fourteen individuals presented with no clinical symptoms and no foci on MR scans. Each family member exhibited no vascular malformations upon examination of the fundus of the eye. All participants provided written informed consent before entering the study. The present study was approved by the ethics committee of Qilu Hospital of Shandong University (Jinan city, Shandong, China).

MRI

All patients underwent conventional MRI using a 3.0T scanner (GE Signa EXCITE II; General Electric, Waukesha, WI, USA), including transverse and axial T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), T2-fluid-attenuated inversion recovery (T2Flair), diffusion weighted imaging (DWI), magnetic resonance angiography (MRA) and spin-echo imaging (SE) sequences. GRE T2*-WI was carried out simultaneously [repeat time/echo time (TR/TE), 520/20 ms; flip angle 20°; section thickness, 6 mm; field of view (FOV), 24x18; matrix, 512x256]. The patients underwent a CT scan prior to MRI.

MRI analysis

Two independent neuroradiologists evaluated the CT and MR images. First, they ascertained whether pathological changes were present in the brain. Second, they decided whether the changes were CCM and identified the different CCM foci shown on various MR sequences. Finally, they determined the location, size and quantity of vascular malformation based on the locations of CCM (cortex-subcortex, basal ganglia, thalamencephalon, brainstem and cerebellum).

Statistical analysis

Data were expressed as the means ± standard deviation. One-way ANOVA and the Newman-Keuls test were used for statistical analysis of the results as appropriate. P<0.05 was considered to indicate a statistically significant result.

Results

Features of CCM in MRI and CT images

Only 3 patients had larger vascular malformations visible in CT scans. The foci were irregular hypodense and hyperdense on the CT scans, usually complicated with hemorrhage and calcification, and were surrounded by a distinct boundary without edema or occupied effect (Fig. 1). With T1WI, T2WI, T2Flair and DWI sequences, the foci showed long T1 and long T2 signal intensities with distinct boundaries. These lesions demonstrated high signal intensities on T2Flair images, high and low mixed signals on T1WI scans, and a core of mixed signal intensity with a surrounding rim of decreased signal intensity on T2WI scans with a distinct boundary and no evident edema. A low signal black rim that completely surrounded the larger lesion with a mixed signal intensity core of high and low signal intensity was typical of CCM; the foci presented as clump-like or ‘popcorn-like’ with a distinct boundary surrounding the foci without edema or occupied effect (Fig. 2).

Figure 1.

CCM on CT, the lesions complicated with hemorrhage and calcification are large enough to be visible on left basal ganglia. The foci show irregular mixed density. CCM, cerebral cavernous malformation; CT, computed tomography.

Figure 2.

(A, B and C) Foci of CCM show long T1 and T2 signal intensity in conventional MRI scans and high signal intensity in DWI scans with a distinct boundary. (A and B) The large focus typically has mixed T1- signal intensity with a core of mixed high and low T2-signal intensity surrounded by a low signal intensity, and a distinct boundary. (D) These lesions demonstrated high signal intensities surrounded by a low signal intensity on T2Flair images. CCM, cerebral cavernous malformation; MRI, magnetic resonance imaging; DWI, diffusion-weighted imaging.

Appearance of CCM by brain MRA

All patients underwent MRA and revealed no abnormality, with the exception of 2 elderly patients who suffered cerebral atherosclerosis and minor angiostenosis (Fig. 3).

Figure 3.

Cerebral vessels by brain MRA showed cerebral atherosclerosis and minor angiostenosis. MRA, magnetic resonance angiography.

Appearance of CCM in SE and GRE T2*-WI scans

The foci were characterized by specific mixed high- and low-signal intensities surrounded by a black rim of decreased signal intensity with a distinct boundary and no occupied effect. Foci at various locations and of different sizes were seen clearly by GRE T2*-WI and more distinctly than by SE (Figs. 4 and 5).

Figure 4.

SE scan showed foci of mixed high and low signal intensity surrounded by a rim of low signal intensity but the foci were not distinct. SE, spin-echo.

Figure 5.

Foci of various sizes were distinctly shown by GRE T2*-WI. The typical focus was characterized by a mixed high and low signal intensity surrounded by a black rim of low signal intensity. GRE T2*-WI, T2*-weighted gradient echo imaging.

Different appearance of CCM in CT, conventional MRI and GRE T2*-WI scans

As shown in Table I, 12 of the 26 members of the 2 families were diagnosed with CCM by GRE T2*-WI. The patients were examined by brain CT and conventional MRI prior to GRE T2*-WI. Multiple foci were detected in all CCM patients by GRE T2*-WI. The numbers of foci observed ranged from 8 to 85 (mean 23) and the foci ranged in size from 2 to 55 mm. Abnormal signal intensities were observed in the images of 9 patients (9/12) by brain T1WI, 8 patients (8/12) by T2WI, 9 patients (9/12) by T2Flair and 10 patients (10/12) by DWI, and 3, 3, 4 and 7 patients were diagnosed with CCM, respectively. The mean numbers of foci detected were 5 (3–26) using T1WI, 5 (2–24) using T2WI, 6 (3–29) using T2Flair and 7 using DWI (6–35). However, of the patients subjected to SE and GRE T2*-WI, 11 patients (11/12) and 12 patients (12/12), respectively, had abnormal signal intensities, and 9 patients (9/12) and 12 patients (12/12), respectively, were diagnosed with CCM. The sensitivity of GRE T2*-WI was much higher than that of CT (P<0.05), but the difference between GRE T2*-WI and other conventional MR sequences had no statistical significance. The mean numbers of detected foci were 17 (7–45) when SE was used and 23 (8–85) when GRE T2*-WI was used. Three patients were observed to have abnormal foci by CT and all were diagnosed with CCM. Three very small CCM lesions were easily detected with GRE T2*-WI but not diagnosed with SE. In addition, multiple foci were detected with greater sensitivity by GRE T2*-WI than by SE and other MR sequences (P<0.05).

Table I.

Comparison of 12 CCM diagnoses obtained by brain CT, conventional MRI, SE and GRE T2*-WI.

Table I.

Comparison of 12 CCM diagnoses obtained by brain CT, conventional MRI, SE and GRE T2*-WI.

VariablesT1WIT2WI T2FlairDWISEGRE T2*-WICT
Patients with detected foci9891011123
Patients with diagnosed CCM33479123
Foci of CCMa5 (3–26)5 (2–24)6 (3–29)7 (6–35)17 (7–45)23 (8–85)1 (0–1)

a Mean (range). CCM, cerebral cavernous malformation; CT, computed tomography; MRI, magnetic resonance imaging; SE, spin-echo imaging; GRE T2*-WI, T2*-weighted gradient echo imaging; T1WI, T1-weighted imaging; T2WI, T2-weighted imaging; T2Flair, T2-fluid-attenuated inversion recovery; DWI, diffusion weighted imaging.

Distribution of foci by GRE T2*-WI (mean)

The foci were distributed as follows: cortex-subcortex, 4 (2–22); basal ganglia, 10 (3–36); thalamencephalon, 4 (1–8); cerebellum, 3 (2–11); and brainstem, 2 (1–7).

Discussion

CCM is a common cerebral malformation and classified as familial (50–67%) and sporadic (33–50%) forms based on patterns of onset (5–10). Sporadic cases are frequently reported while familial CCM is rare in China. CCM is composed of numerous micrangium with dilated thin walls separated by nerve fibers. However, normal brain tissue is not observed among blood sinuses that lack elastic fibers and muscle tissues. Hemorrhage is common. Progressive neurological deficits, seizures and headaches are reported to be characteristic of episodes of rebleeding in the brainstem and cerebral cavernomas (11–13). The prevalence of CCM in the general population has been estimated to be 0.4–0.8%, accounting for 10–20% of vascular malformations in the central nervous system (10,14–16). CCM was previously diagnosed post mortem but may be diagnosed ante mortem with the widespread use of CT and MR techniques. With brain MRI in particular, cases of FCCM and multiple brain CCM may be identified and the natural history and developmental process of CCM are well understood (9,17). The features of FCCM on brain CT and MR images are associated with the pathological structure and the development of cavernous vascular malformations (18). Only 3 of the12 patients suffering from clinical symptoms were diagnosed with CCM by brain CT, a positive diagnosis rate of 25%. The 3 patients presented with headache, movement and sensory problems affecting the limbs or speech disfluency. Foci having an abnormally high density or mixed high and low density were observed by brain CT; calcification and a distinct boundary without a surrounding zone of edema or occupied effect distinguished them from cerebral hemorrhage. The foci were located in the subcortex or basal ganglia region. The 3 patients were finally diagnosed as having multiple CCM of the brain by MRI which revealed numerous microfoci in addition to the larger foci identified by CT. The microfoci were not shown in the brain CT images. Similarly, the 9 other patients with brain multiple vascular malformations ascertained by MRI had no or minor symptoms or signs due to the microfoci which were not shown by CT. The foci identified in the brainstem and cerebellum by MRI were also not shown by CT. Therefore, brain CT is only sensitive to the larger vascular malformations with hemorrhage and calcification. The foci which showed irregular mixed high and low density without specificity and microvascular malformations were not shown by CT. The diagnosis of FCCM by brain CT is clearly limited.

Brain MRI is much more sensitive to CCM than CT, particularly when the focus is located in the posterior cranial fossa or brainstem (19,20). The focus of CCM, particularly of CCM with chronic repeated hemorrhage, is clearly seen by MRI due to methemoglobin, hemosiderin deposition, thrombus, calcification and surrounding reactive gliosis induced by repeated and multiple hemorrhaging of the vascular malformation. The MRI signal intensities of the foci vary according to the hemorrhagic period. The foci show high T1-signal intensity and low T2-signal intensity in the acute stage, and mixed high and low signal intensity in chronic phase due to nomadic diluted methemoglobin and hemosiderin deposition. The phenomenon of hemosiderin deposition occurs 1 week after hemorrhage of the CCM and shows first at the perimeter and extends to the core of focus. The area of hemosiderin deposition shows lasting low T1 and T2 signal intensity, clearly by T2WI with a surrounding black rim of hemosiderin deposition enhanced by reactive gliosis which shows long T1 and T2 signal intensity. However, it was not possible to identify all CCM patients and their respective foci using conventional MRI. T1WI, T2WI, T2Flair and DWI identified abnormal signal intensities in 9, 8, 9 and 10 of the 12 patients, respectively, and 3, 3, 4 and 7 of the patients, respectively, were diagnosed with CCM. The mean numbers of foci detected were 5, 5, 6 and 7, respectively. However, SE and GRE T2*-WI detected abnormal signal intensities in 11 and 12 patients, respectively, and diagnosed CCM in 9 and 12 patients, respectively; the mean numbers of foci detected were 17 and 23, respectively. Microvascular malformations from three patients that were not observed by SE were easily identified using GRE T2*-WI. GRE T2*-WI was more sensitive to multiple foci than SE, and accurately and reliably ascertained CCM of the brainstem and cerebellum. Conventional MRI has more notably increased the detection of abnormal foci than CT, but has a limitation in decision of focal property, namely, although the focus was observed the etiological diagnosis of the focus was confined. We suggest that the reason for the difference between GRE T2*-WI and other conventional MR sequences being not statistically significant is that the number of patients studied is too few. However, GRE T2*-WI not only accurately identified all foci of each size but also provided a qualitative diagnosis based on their features. Therefore, we consider that GRE T2*-WI is a ‘gold’ standard for the diagnosis of CCM and is almost as reliable as autopsy.

The 12 patients with FCCM all had multiple foci; the foci ranged in number from 8 to 85 and in size from 2 to 55 mm. The 3 patients who had larger foci with repeated hemorrhage and calcification were clearly identified with CT. Multiple foci were a common feature of the FCCM cases studied. Non-familial CCM is common in the clinic and usually comprises a single focus. The foci of FCCM may be located in every region of the central nervous system. The foci of our studied patients were almost all supratentorial, while others were subtentorial. The majority were located at the basal ganglia, with a mean of 11 foci, and the larger foci of the 3 patients identified by CT were all located on this region. The next most common locations was the cortex-subcortex with a mean of 4 foci. Foci were also located in the cerebral ganglion (4), cerebellum (3) and brainstem (2). Brainstem CCM foci were mostly located in the pons, and were also located in the midbrain but rarely in the medulla oblongata. Spinal cord MRI was not performed due to the lack of symptoms relating to the spinal cord. Therefore, the current study is not completely representative of the distribution of CCM in the central nervous system in the population.

In conclusion, GRE T2*-WI is an available technique for detecting FCCM. Conventional brain MRI should be performed to detect multiple foci of CCM, particularly in the members of a family affected by FCCM. In addition, GRE T2*-WI is significant in the early diagnosis and treatment of FCCM.

Acknowledgements

This study was supported by the National Natural Science Foundation of China (No. H0905) and the National Natural Science Foundation of Shandong province (No. ZR2010HM052)

References

1. 

Hsu FPK, Rigamonti D and Huhn SL: Epidemiology of cavernous malformations. Cavernous Malformations. Awad IA and Barrow DL: American Association of Neurological Surgeons; Park Ridge, IL: pp. 13–23. 1993

2. 

Ohue S, Fukushima T, Friedman AH, et al: Retrosigmoid suprafloccular transhorizontal fissure approach for resection of brainstem cavernous malformation. Neurosurgery. 66(Suppl 6): S306–S312. 2010. View Article : Google Scholar

3. 

Labauge P, Brunereau L, Lévy C, et al: The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients. Neuroradiology. 42:327–332. 2000. View Article : Google Scholar : PubMed/NCBI

4. 

Wurm G and Fellner FA: Implementation of T2*-weighted MR for multimodal image guidance in cerebral cavernomas. Neuroimage. 22:841–846. 2004.

5. 

Denier C, Goutagny S, Labauge P, et al: Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet. 74:326–337. 2004. View Article : Google Scholar : PubMed/NCBI

6. 

Kim DS, Park YG, Choi JU, et al: An analysis of the natural history of cavernous malformations. Surg Neurol. 48:9–17. 1997. View Article : Google Scholar

7. 

Moriarity JL, Wetzel M, Clatterbuck RE, et al: The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery. 44:1166–1173. 1999.PubMed/NCBI

8. 

Otten P, Pizzolato GP, Rilliet B and Berney J: 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie. 35:82–83. 1989.(In French).

9. 

Rigamonti D, Hadley MN, Drayer BP, et al: Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med. 319:343–347. 1988. View Article : Google Scholar : PubMed/NCBI

10. 

Robinson JR, Awad IA and Little JR: Natural history of the cavernous angioma. J Neurosurg. 75:709–714. 1991. View Article : Google Scholar : PubMed/NCBI

11. 

Fritschi JA, Reulen HJ, Spetzler RF and Zabramski JM: Cavernous malformations of the brain stem: a review of 139 cases. Acta Neurochir. 130:35–46. 1994. View Article : Google Scholar : PubMed/NCBI

12. 

Kondziolka D, Lunsford LD and Kestle JR: The natural history of cerebral cavernous malformations. J Neurosurg. 83:820–824. 1995. View Article : Google Scholar : PubMed/NCBI

13. 

Krraemer DL and Awad IA: Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia. 35(Suppl 6): S30–S43. 1994. View Article : Google Scholar : PubMed/NCBI

14. 

Gunel M, Awad IA, Finberg K, et al: A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med. 334:946–951. 1996. View Article : Google Scholar : PubMed/NCBI

15. 

Laberge-le Couteulx S, Jung HH, Labauge P, et al: Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet. 23:189–193. 1999.PubMed/NCBI

16. 

Del Curling O Jr, Kelly DL Jr, Elster AD and Craven TE: An analysis of the natural history of cavernous angiomas. J Neurosurg. 75:702–708. 1991.PubMed/NCBI

17. 

Moriarity JL, Clatterbuck RE and Rigamonti D: The natural history of cavernous malformations. Neurosurg Clin N Am. 10:411–417. 1999.

18. 

Kattapong VJ, Hart BL and Davis LE: Familial cerebral cavernous angiomas: clinical and radiologic studies. Neurology. 45:492–497. 1995. View Article : Google Scholar : PubMed/NCBI

19. 

Chi LY, Wang SH, Liu XW, et al: Familial cerebral cavernous malformation: features of clinical manifestation, pathology and imaging in a Chinese family. Cerebrovasc Dis. 26:206–208. 2008. View Article : Google Scholar

20. 

Zabramski JM, Wascher TM, Spetzler RF, et al: The natural history of familial cerebral cavernomas: results of an ongoing study. J Neurosurg. 80:422–432. 1994. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liu X, Wang S, Chi Z, Su L, Zhao X and Wang S: The value of T2*-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families. Exp Ther Med 5: 448-452, 2013.
APA
Liu, X., Wang, S., Chi, Z., Su, L., Zhao, X., & Wang, S. (2013). The value of T2*-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families. Experimental and Therapeutic Medicine, 5, 448-452. https://doi.org/10.3892/etm.2012.845
MLA
Liu, X., Wang, S., Chi, Z., Su, L., Zhao, X., Wang, S."The value of T2*-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families". Experimental and Therapeutic Medicine 5.2 (2013): 448-452.
Chicago
Liu, X., Wang, S., Chi, Z., Su, L., Zhao, X., Wang, S."The value of T2*-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families". Experimental and Therapeutic Medicine 5, no. 2 (2013): 448-452. https://doi.org/10.3892/etm.2012.845
Copy and paste a formatted citation
x
Spandidos Publications style
Liu X, Wang S, Chi Z, Su L, Zhao X and Wang S: The value of T2*-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families. Exp Ther Med 5: 448-452, 2013.
APA
Liu, X., Wang, S., Chi, Z., Su, L., Zhao, X., & Wang, S. (2013). The value of T2*-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families. Experimental and Therapeutic Medicine, 5, 448-452. https://doi.org/10.3892/etm.2012.845
MLA
Liu, X., Wang, S., Chi, Z., Su, L., Zhao, X., Wang, S."The value of T2*-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families". Experimental and Therapeutic Medicine 5.2 (2013): 448-452.
Chicago
Liu, X., Wang, S., Chi, Z., Su, L., Zhao, X., Wang, S."The value of T2*-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families". Experimental and Therapeutic Medicine 5, no. 2 (2013): 448-452. https://doi.org/10.3892/etm.2012.845
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team